$LXRX
LEXICON PHARMACEUTICALS, INC.

2013 Q1 Form 10-K Financial Statement

#000106282213000008 Filed on March 11, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 2011 Q4
Revenue $360.0K $1.089M $343.0K
YoY Change 20.0% -41.1% -73.62%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.300M $17.00M $4.000M
YoY Change -23.21% -2.3% 2.56%
% of Gross Profit
Research & Development $20.33M $82.57M $28.10M
YoY Change -11.76% -10.08% 53.55%
% of Gross Profit
Depreciation & Amortization $793.0K $4.190M $1.100M
YoY Change -29.51% -14.26% -15.38%
% of Gross Profit
Operating Expenses $25.92M $109.5M $33.70M
YoY Change -12.69% -5.55% 42.19%
Operating Profit -$25.56M -$108.4M -$33.34M
YoY Change -13.03% -4.98%
Interest Expense $506.0K $2.114M -$500.0K
YoY Change -5.77% -16.38% -16.67%
% of Operating Profit
Other Income/Expense, Net $34.00K $318.0K $0.00
YoY Change -950.0% 107.84%
Pretax Income -$26.00M -$110.2M -$33.80M
YoY Change -13.04% -5.17% 46.96%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$25.97M -$110.2M -$33.85M
YoY Change -13.04% -5.17% 47.15%
Net Earnings / Revenue -7215.0% -10120.39% -9867.35%
Basic Earnings Per Share
Diluted Earnings Per Share -$355.2K -$1.574M -$676.0K
COMMON SHARES
Basic Shares Outstanding 513.0M shares 337.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q1 2012 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $196.7M $222.8M $281.3M
YoY Change -22.31% -20.8% 33.25%
Cash & Equivalents $34.25M $30.40M $186.3M
Short-Term Investments $162.5M $192.4M $95.00M
Other Short-Term Assets $8.438M $6.700M $3.748M
YoY Change 64.07% 63.41% 30.0%
Inventory
Prepaid Expenses
Receivables $863.0K $1.400M $350.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $206.5M $230.9M $285.8M
YoY Change -20.28% -19.21% 33.09%
LONG-TERM ASSETS
Property, Plant & Equipment $42.62M $42.60M $46.42M
YoY Change -6.38% -8.19% -13.12%
Goodwill $44.54M $44.54M
YoY Change 0.0% 0.0%
Intangibles $53.56M $53.56M
YoY Change 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets $88.00K $100.0K $205.0K
YoY Change -51.38% -50.0% -66.88%
Total Long-Term Assets $140.8M $140.9M $144.7M
YoY Change -2.08% -2.63% -4.88%
TOTAL ASSETS
Total Short-Term Assets $206.5M $230.9M $285.8M
Total Long-Term Assets $140.8M $140.9M $144.7M
Total Assets $347.3M $371.8M $430.5M
YoY Change -13.78% -13.64% 17.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.442M $7.700M $6.042M
YoY Change 2.22% 28.33% 91.26%
Accrued Expenses $9.704M $8.900M $13.79M
YoY Change -29.22% -35.51% 120.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.607M $1.600M $1.443M
YoY Change 8.73% 14.29% 26.8%
Total Short-Term Liabilities $17.38M $18.30M $21.39M
YoY Change -16.97% -14.49% 98.52%
LONG-TERM LIABILITIES
Long-Term Debt $21.46M $21.90M $23.45M
YoY Change -6.96% -6.81% -14.24%
Other Long-Term Liabilities $34.08M $46.20M $55.15M
YoY Change -40.39% -33.43% 13.04%
Total Long-Term Liabilities $55.54M $68.10M $78.60M
YoY Change -30.78% -26.7% 3.24%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.38M $18.30M $21.39M
Total Long-Term Liabilities $55.54M $68.10M $78.60M
Total Liabilities $105.1M $105.1M $132.9M
YoY Change -21.49% -20.92% 10.92%
SHAREHOLDERS EQUITY
Retained Earnings -$925.8M -$789.6M
YoY Change 12.97% 17.26%
Common Stock $514.0K $480.0K
YoY Change 6.86% 42.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.503M $345.0K
YoY Change 138.57% 45.57%
Treasury Stock Shares 814.0K shares 218.0K shares
Shareholders Equity $242.2M $266.7M $297.6M
YoY Change
Total Liabilities & Shareholders Equity $347.3M $371.8M $430.5M
YoY Change -13.78% -13.64% 17.34%

Cashflow Statement

Concept 2013 Q1 2012 2011 Q4
OPERATING ACTIVITIES
Net Income -$25.97M -$110.2M -$33.85M
YoY Change -13.04% -5.17% 47.15%
Depreciation, Depletion And Amortization $793.0K $4.190M $1.100M
YoY Change -29.51% -14.26% -15.38%
Cash From Operating Activities -$24.27M -$94.46M -$22.50M
YoY Change -10.11% 7.42% 15.98%
INVESTING ACTIVITIES
Capital Expenditures $839.0K $492.0K -$200.0K
YoY Change 258.55% -59.2% 0.0%
Acquisitions $0.00
YoY Change
Other Investing Activities $29.90M -$97.30M $18.30M
YoY Change -123.12% -236.66% -112.64%
Cash From Investing Activities $29.11M -$97.81M $18.10M
YoY Change -122.46% -239.81% -112.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $624.0K -$37.82M
YoY Change 167.81% -76.46%
Debt Paid & Issued, Net $387.0K $1.443M
YoY Change 9.63% -59.79%
Cash From Financing Activities -$1.011M $36.38M 160.3M
YoY Change 40.03% -76.84% -80250.0%
NET CHANGE
Cash From Operating Activities -$24.27M -$94.46M -22.50M
Cash From Investing Activities $29.11M -$97.81M 18.10M
Cash From Financing Activities -$1.011M $36.38M 160.3M
Net Change In Cash $3.825M -$155.9M 155.9M
YoY Change -102.43% -212.07% -194.66%
FREE CASH FLOW
Cash From Operating Activities -$24.27M -$94.46M -$22.50M
Capital Expenditures $839.0K $492.0K -$200.0K
Free Cash Flow -$25.11M -$94.95M -$22.30M
YoY Change -7.81% 6.52% 16.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7661000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6042000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1378000 USD
CY2011Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
350000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8922000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13786000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
80535000 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
83416000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
21000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
23000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1087033000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1166605000 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6495000 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5707000 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5116000 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35000 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
35000 USD
CY2012Q4 us-gaap Assets
Assets
371778000 USD
CY2011Q4 us-gaap Assets
Assets
430512000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
230935000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
285790000 USD
CY2010Q3 us-gaap Business Acquisition Purchase Price Allocation Assets Acquired
BusinessAcquisitionPurchasePriceAllocationAssetsAcquired
58541000 USD
CY2010Q3 us-gaap Business Acquisition Purchase Price Allocation Assets Acquired Liabilities Assumed Net
BusinessAcquisitionPurchasePriceAllocationAssetsAcquiredLiabilitiesAssumedNet
55557000 USD
CY2010Q3 us-gaap Business Acquisition Purchase Price Allocation Current Assets Cash And Cash Equivalents
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsCashAndCashEquivalents
4439000 USD
CY2010Q3 us-gaap Business Acquisition Purchase Price Allocation Current Assets Prepaid Expense And Other Assets
BusinessAcquisitionPurchasePriceAllocationCurrentAssetsPrepaidExpenseAndOtherAssets
545000 USD
CY2010Q3 us-gaap Business Acquisition Purchase Price Allocation Current Liabilities Accounts Payable
BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayable
-2984000 USD
CY2010Q3 us-gaap Business Acquisition Purchase Price Allocation Deferred Income Taxes Asset Liability Net
BusinessAcquisitionPurchasePriceAllocationDeferredIncomeTaxesAssetLiabilityNet
-18745000 USD
CY2010Q3 us-gaap Business Acquisition Purchase Price Allocation Goodwill Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillAmount
18745000 USD
CY2010Q3 us-gaap Business Acquisition Purchase Price Allocation Intangible Assets Not Amortizable
BusinessAcquisitionPurchasePriceAllocationIntangibleAssetsNotAmortizable
53557000 USD
CY2010Q3 us-gaap Business Acquisition Purchase Price Allocation Liabilities Assumed
BusinessAcquisitionPurchasePriceAllocationLiabilitiesAssumed
-21729000 USD
CY2010 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-97818000 USD
CY2010 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
4908000 USD
CY2010Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
36812000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30423000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186309000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47208000 USD
CY2009Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
100554000 USD
CY2010 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-53346000 USD
CY2011 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
139101000 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-155886000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
480000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
512000 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-110209000 USD
CY2010 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-101770000 USD
CY2011 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-116199000 USD
CY2011 us-gaap Contracts Revenue
ContractsRevenue
1632000 USD
CY2010 us-gaap Contracts Revenue
ContractsRevenue
4191000 USD
CY2012 us-gaap Contracts Revenue
ContractsRevenue
783000 USD
CY2010 us-gaap Cumulative Effect Adjustment Gross Losses
CumulativeEffectAdjustmentGrossLosses
-1456000 USD
CY2010 us-gaap Cumulative Effect On Retained Earnings Before Tax1
CumulativeEffectOnRetainedEarningsBeforeTax1
1500000 USD
CY2012Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0823
CY2011Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
-19088000 USD
CY2012Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
-19085000 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
119000 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
128000 USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
14212000 USD
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
13910000 USD
CY2012Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
4906000 USD
CY2011Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
5008000 USD
CY2011Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
315336000 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
348791000 USD
CY2012Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
71839000 USD
CY2011Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
60938000 USD
CY2011Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
195810000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
216579000 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
394300000 USD
CY2011Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
7126000 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
10429000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
32066000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
34611000 USD
CY2011Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11843000 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
12972000 USD
CY2011Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-314993000 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
-348451000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
-18745000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
-18745000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
18745000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
18745000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-343000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
-340000 USD
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
490000 USD
CY2010 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
642000 USD
CY2011 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
583000 USD
CY2010 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5394000 USD
CY2011 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4887000 USD
CY2012 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4190000 USD
CY2010 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2011 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2012Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2012Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2011Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2011Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2011Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2012Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
10200000 USD
CY2011 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
6766000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
9887000 USD
CY2010 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
45557000 USD
CY2012 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-35000000 USD
CY2012Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
29920000 USD
CY2011Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
55033000 USD
CY2010Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
48267000 USD
CY2011 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17043000 USD
CY2011 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17350000 USD
CY2009Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0 USD
CY2012 us-gaap Gain Loss On Investments
GainLossOnInvestments
0 USD
CY2010 us-gaap Gain Loss On Investments
GainLossOnInvestments
141000 USD
CY2010 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
2710000 USD
CY2010 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19396000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
44543000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
44543000 USD
CY2010 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1001000 USD
CY2012 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2011 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
704000 USD
CY2011 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
800000 USD
CY2010 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
900000 USD
CY2011 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-116215000 USD
CY2010 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-101801000 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-110211000 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2011 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2010 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-26000 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2010 us-gaap Income Taxes Paid
IncomeTaxesPaid
-26000 USD
CY2011 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
995000 USD
CY2010 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5238000 USD
CY2011 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10365000 USD
CY2010 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-488000 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1028000 USD
CY2011 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-394000 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
293000 USD
CY2010 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
728000 USD
CY2011 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
95000 USD
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
96000 USD
CY2011 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
414000 USD
CY2010 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-218000 USD
CY2010 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6704000 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2601000 USD
CY2011 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-865000 USD
CY2010 us-gaap Indefinite Lived Intangible Assets Acquired During Period
IndefiniteLivedIntangibleAssetsAcquiredDuringPeriod
43557000 USD
CY2011 us-gaap Indefinite Lived Intangible Assets Acquired During Period
IndefiniteLivedIntangibleAssetsAcquiredDuringPeriod
0 USD
CY2012 us-gaap Indefinite Lived Intangible Assets Acquired During Period
IndefiniteLivedIntangibleAssetsAcquiredDuringPeriod
0 USD
CY2012 us-gaap Interest Expense
InterestExpense
2114000 USD
CY2011 us-gaap Interest Expense
InterestExpense
2528000 USD
CY2010 us-gaap Interest Expense
InterestExpense
2719000 USD
CY2011 us-gaap Interest Paid Net
InterestPaidNet
2447000 USD
CY2012 us-gaap Interest Paid Net
InterestPaidNet
2028000 USD
CY2010 us-gaap Interest Paid Net
InterestPaidNet
2424000 USD
CY2011 us-gaap Investment Income Interest
InvestmentIncomeInterest
255000 USD
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
213000 USD
CY2010 us-gaap Investment Income Interest
InvestmentIncomeInterest
519000 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2200000 USD
CY2011 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2500000 USD
CY2010 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2500000 USD
CY2010 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
142866000 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36381000 USD
CY2014Q2 us-gaap Mortgage Loans On Real Estate Periodic Payment Terms Balloon Payment Amount
MortgageLoansOnRealEstatePeriodicPaymentTermsBalloonPaymentAmount
21400000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
132944000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
105100000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
430512000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
371778000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
21390000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18285000 USD
CY2012 us-gaap Licenses Revenue
LicensesRevenue
306000 USD
CY2010 us-gaap Licenses Revenue
LicensesRevenue
717000 USD
CY2011 us-gaap Licenses Revenue
LicensesRevenue
217000 USD
CY2012Q4 us-gaap Long Term Debt
LongTermDebt
23451000 USD
CY2012Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1574000 USD
CY2011Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
1443000 USD
CY2012Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1574000 USD
CY2012Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
21877000 USD
CY2011Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
23451000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21877000 USD
CY2011 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
157084000 USD
CY2010 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-113844000 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-97807000 USD
CY2011 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
69955000 USD
CY2011 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-87938000 USD
CY2010 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-82368000 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-94460000 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-101775000 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-110211000 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-116215000 USD
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-29868000 USD
CY2011Q4 us-gaap Net Income Loss
NetIncomeLoss
-33845000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-29539000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-26103000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-25931000 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
-26638000 USD
CY2011Q1 us-gaap Net Income Loss
NetIncomeLoss
-29629000 USD
CY2012Q4 us-gaap Net Income Loss
NetIncomeLoss
-24873000 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
109504000 USD
CY2010 us-gaap Operating Expenses
OperatingExpenses
100626000 USD
CY2011 us-gaap Operating Expenses
OperatingExpenses
115944000 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-108415000 USD
CY2011 us-gaap Operating Income Loss
OperatingIncomeLoss
-114095000 USD
CY2010 us-gaap Operating Income Loss
OperatingIncomeLoss
-95718000 USD
CY2012Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-24492000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
5164000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
230000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-29060000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25691000 USD
CY2011Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-29136000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25926000 USD
CY2011Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-33342000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-25480000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-29383000 USD
CY2010Q3 lxrx Symphony Contingent Payment Percentage
SymphonyContingentPaymentPercentage
0.50
CY2010Q3 lxrx Symphony Payment In Stock Limitation
SymphonyPaymentInStockLimitation
0.50
CY2010Q3 lxrx Symphony Regulatory Approval Payment
SymphonyRegulatoryApprovalPayment
15000000 USD
CY2010Q3 lxrx Symphony Regulatory Approval Percentage Limit
SymphonyRegulatoryApprovalPercentageLimit
0.50
CY2010Q3 lxrx Symphony Regulatory Approval Reduction Percentage
SymphonyRegulatoryApprovalReductionPercentage
0.50
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1129000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1103000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1078000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1052000 USD
CY2012Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
572000 USD
CY2012Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
602500000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
6349000 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3748000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
205000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
109000 USD
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000 USD
CY2010 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
5000 USD
CY2011 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
16000 USD
CY2012Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
53557000 USD
CY2011Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
53557000 USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55146000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
32283000 USD
CY2010 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4024000 USD
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
105000 USD
CY2011 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
153000 USD
CY2010 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
149000 USD
CY2012 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
285000 USD
CY2011 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
108000 USD
CY2010Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
300000 USD
CY2012Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
200000 USD
CY2011 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2012 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2010 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5561000 USD
CY2011 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
108092000 USD
CY2012 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
233250000 USD
CY2010 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
155856000 USD
CY2010 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1132000 USD
CY2011 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1206000 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
492000 USD
CY2012Q4 lxrx Tigm Maximum Exposure
TigmMaximumExposure
14200000 USD
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2011Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2011Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2011Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2011Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2010 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
181496000 USD
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
38109000 USD
CY2011 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
160781000 USD
CY2010 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
11377000 USD
CY2011 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2012 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2010 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
48641000 USD
CY2012 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
135850000 USD
CY2011 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
176628000 USD
CY2010 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
64000 USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
85000 USD
CY2011 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2625000 USD
CY2011Q2 us-gaap Proceeds From Sale Of Real Estate
ProceedsFromSaleOfRealEstate
2400000 USD
CY2010 us-gaap Profit Loss
ProfitLoss
-101775000 USD
CY2011 us-gaap Profit Loss
ProfitLoss
-116215000 USD
CY2012 us-gaap Profit Loss
ProfitLoss
-110211000 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
126952000 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
126050000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
46417000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42634000 USD
CY2012Q3 us-gaap Revenues
Revenues
372000 USD
CY2011Q3 us-gaap Revenues
Revenues
355000 USD
CY2012Q1 us-gaap Revenues
Revenues
300000 USD
CY2011 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
CY2012 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
CY2010 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
0 USD
CY2010 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
49858000 USD
CY2011 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3589000 USD
CY2012 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1443000 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
82574000 USD
CY2010 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
78520000 USD
CY2011 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
91828000 USD
CY2012Q4 us-gaap Restricted Investments
RestrictedInvestments
430000 USD
CY2011Q4 us-gaap Restricted Investments
RestrictedInvestments
430000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-789621000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-899832000 USD
CY2012 us-gaap Revenues
Revenues
1089000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.37
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.40
CY2012 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-285000 USD
CY2011 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
16000 USD
CY2011 us-gaap Revenues
Revenues
1849000 USD
CY2010 us-gaap Revenues
Revenues
4908000 USD
CY2012Q4 us-gaap Revenues
Revenues
218000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2500000 USD
CY2012Q2 us-gaap Revenues
Revenues
199000 USD
CY2010 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
5000 USD
CY2011Q4 us-gaap Revenues
Revenues
343000 USD
CY2011Q2 us-gaap Revenues
Revenues
555000 USD
CY2011Q1 us-gaap Revenues
Revenues
596000 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
6495000 USD
CY2011 us-gaap Share Based Compensation
ShareBasedCompensation
5707000 USD
CY2010 us-gaap Share Based Compensation
ShareBasedCompensation
5478000 USD
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
25397414 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
19662769 shares
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
63000 USD
CY2010 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1100 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
462000 USD
CY2011 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.36
CY2012 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
2000 USD
CY2012Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1900000 USD
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y1M
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
95383000 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
192785000 USD
CY2010Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
161770206 shares
CY2012Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
17500000 shares
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
181474000 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
160592000 USD
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
37055000 USD
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1054000 USD
CY2010 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22000 USD
CY2011 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
552000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
297568000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
266678000 USD
CY2010Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
247024000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
266678000 USD
CY2009Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
163497000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
297568000 USD
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
380000 shares
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
218000 shares
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
345000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
630000 USD
CY2011 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-108000 USD
CY2010 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
-149000 USD
CY2010 lxrx Entity Wide Revenue Taconic Farms Percentage
EntityWideRevenueTaconicFarmsPercentage
0.35
CY2012 lxrx Entity Wide Revenue Taconic Farms Percentage
EntityWideRevenueTaconicFarmsPercentage
0.68
CY2012 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates:</font><font style="font-family:inherit;font-size:10pt;"> The preparation of financial statements in conformity with U. S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Actual results could differ from those estimates.</font></div></div>
CY2012 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
33500000 USD
CY2011 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
340761000 shares
CY2010 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
302844000 shares
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
489707000 shares
CY2012Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
480324000 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
490049000 shares
CY2011Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
337527000 shares
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
480634000 shares
CY2011Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
337678000 shares
CY2011Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
337668000 shares
CY2012Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
507619000 shares
CY2011Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
350069000 shares
CY2010 lxrx Amortization Expense For Purchase Option
AmortizationExpenseForPurchaseOption
4000000 USD
CY2011 lxrx Amortization Of Symphony Icon Inc Purchase Option
AmortizationOfSymphonyIconIncPurchaseOption
0 USD
CY2012 lxrx Amortization Of Symphony Icon Inc Purchase Option
AmortizationOfSymphonyIconIncPurchaseOption
0 USD
CY2010 lxrx Amortization Of Symphony Icon Inc Purchase Option
AmortizationOfSymphonyIconIncPurchaseOption
3957000 USD
CY2012Q4 lxrx Buildings Collateral
BuildingsCollateral
58900000 USD
CY2010 lxrx Change In Fair Value Of Symphony Icon Inc Purchase Liability
ChangeInFairValueOfSymphonyIconIncPurchaseLiability
2710000 USD
CY2012 lxrx Change In Fair Value Of Symphony Icon Inc Purchase Liability
ChangeInFairValueOfSymphonyIconIncPurchaseLiability
9887000 USD
CY2011 lxrx Change In Fair Value Of Symphony Icon Inc Purchase Liability
ChangeInFairValueOfSymphonyIconIncPurchaseLiability
6766000 USD
CY2001Q3 lxrx Coelacanth Goodwill
CoelacanthGoodwill
25800000 USD
CY2001Q3 lxrx Coelacanth Purchase Price
CoelacanthPurchasePrice
36000000 USD
CY2010 lxrx Deconsolidation Of Symphony Icon Inc
DeconsolidationOfSymphonyIconInc
290000 USD
CY2012Q4 lxrx Deferred Tax Liability Related To Acquisition Of Symphony Icon
DeferredTaxLiabilityRelatedToAcquisitionOfSymphonyIcon
-18745000 USD
CY2011Q4 lxrx Deferred Tax Liability Related To Acquisition Of Symphony Icon
DeferredTaxLiabilityRelatedToAcquisitionOfSymphonyIcon
-18745000 USD
CY2012Q4 lxrx Directors Annual Option Grant
DirectorsAnnualOptionGrant
20000 shares
CY2012Q4 lxrx Directors Annual Restricted Stock Award Value
DirectorsAnnualRestrictedStockAwardValue
20000 USD
CY2012Q4 lxrx Directors Intial Option Grant
DirectorsIntialOptionGrant
30000 shares
CY2010 lxrx Disclosure On Geographic Areas Revenue From External Customers Attributed To Entitys Country Of Domicile Percent
DisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicilePercent
0.94
CY2012 lxrx Disclosure On Geographic Areas Revenue From External Customers Attributed To Entitys Country Of Domicile Percent
DisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicilePercent
1.00
CY2011 lxrx Disclosure On Geographic Areas Revenue From External Customers Attributed To Entitys Country Of Domicile Percent
DisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEntitysCountryOfDomicilePercent
1.00
CY2011 lxrx Entity Wide Revenue Taconic Farms Percentage
EntityWideRevenueTaconicFarmsPercentage
0.46
CY2011 lxrx Entity Wide Revenue Texas Am Institute For Genomic Medicine Percentage
EntityWideRevenueTexasAmInstituteForGenomicMedicinePercentage
0.20
CY2007Q2 lxrx Holdings Contribution To Icon
HoldingsContributionToIcon
45000000 USD
CY2007Q3 lxrx Invus Purchase Shares
InvusPurchaseShares
50824986 shares
CY2010 lxrx Disclosure On Geographic Areas Revenue From External Customers Attributed To Europe Percent
DisclosureOnGeographicAreasRevenueFromExternalCustomersAttributedToEuropePercent
0.06
CY2012 lxrx Employee Service Share Based Compensation Outstanding Weighted Average Remaining Vesting Period
EmployeeServiceShareBasedCompensationOutstandingWeightedAverageRemainingVestingPeriod
P1Y4M
CY2012 lxrx Entity Wide Revenue Deltagen Percentage
EntityWideRevenueDeltagenPercentage
0.25
CY2012Q4 lxrx Land Collateral
LandCollateral
2700000 USD
CY2010Q3 lxrx Lexicon Paid Holdings Cash
LexiconPaidHoldingsCash
10000000 USD
CY2007Q2 lxrx Lexicon Received Cash From Holdings
LexiconReceivedCashFromHoldings
15000000 USD
CY2011 lxrx Entity Wide Revenue United States Army Medical Research Acquisition Activity Percentage
EntityWideRevenueUnitedStatesArmyMedicalResearchAcquisitionActivityPercentage
0.20
CY2010 lxrx Entity Wide Revenue United States Army Medical Research Acquisition Activity Percentage
EntityWideRevenueUnitedStatesArmyMedicalResearchAcquisitionActivityPercentage
0.23
CY2012Q4 lxrx Limit On Shares That May Be Issued Other Than Stock Options Or Sars Equity Incentive Plan
LimitOnSharesThatMayBeIssuedOtherThanStockOptionsOrSarsEquityIncentivePlan
15000000 shares
CY2010Q1 lxrx Net Proceeds From Stock Offering
NetProceedsFromStockOffering
181500000 USD
CY2007Q2 lxrx Fair Value Of Stock Issued To Holdings
FairValueOfStockIssuedToHoldings
23600000 USD
CY2007Q2 lxrx Lexicon Sold Shares To Holdings
LexiconSoldSharesToHoldings
7650622 shares
CY2012Q4 lxrx Net Proceeds From Stock Offering
NetProceedsFromStockOffering
37100000 USD
CY2012Q4 lxrx Offering Price Per Share
OfferingPricePerShare
2.25
CY2010Q1 lxrx Offering Price Per Share
OfferingPricePerShare
1.15
CY2012Q4 lxrx Options Outstanding Equity Incentive Plan
OptionsOutstandingEquityIncentivePlan
20679439 shares
CY2012Q4 lxrx Options Outstanding Non Employee Directors Equity Incentive Plan
OptionsOutstandingNonEmployeeDirectorsEquityIncentivePlan
846000 shares
CY2010Q1 lxrx Payments Of Underwriting Discounts And Commissions
PaymentsOfUnderwritingDiscountsAndCommissions
4300000 USD
CY2012Q4 lxrx Payments Of Underwriting Discounts And Commissions
PaymentsOfUnderwritingDiscountsAndCommissions
2000000 USD
CY2012 lxrx Restricted Stock Purchase Price As Percent Of Value Of Common Stock
RestrictedStockPurchasePriceAsPercentOfValueOfCommonStock
0.85
CY2012Q4 lxrx Restricted Stock Units Outstanding Equity Incentive Plan
RestrictedStockUnitsOutstandingEquityIncentivePlan
3871975 shares
CY2011Q4 lxrx Rights Offering Invus Ownership Percentage
RightsOfferingInvusOwnershipPercentage
0.50
CY2011Q4 lxrx Rights Offering Invus Shares
RightsOfferingInvusShares
115044247 shares
CY2011Q4 lxrx Rights Offering Net Proceeds
RightsOfferingNetProceeds
160600000 USD
CY2011Q4 lxrx Rights Offering Offering Expenses
RightsOfferingOfferingExpenses
400000 USD
CY2011Q4 lxrx Rights Offering Price Per Share
RightsOfferingPricePerShare
1.13
CY2011Q4 lxrx Rights Offering Shares
RightsOfferingShares
142492883 shares
CY2011Q4 lxrx Rights Offering Stock Price
RightsOfferingStockPrice
1.14
CY2011 lxrx Share Based Compensation Arrangement By Share Based Payment Award Stock Bonus And Restricted Stock Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockBonusAndRestrictedStockGrantsInPeriod
200277 shares
CY2012 lxrx Share Based Compensation Arrangement By Share Based Payment Award Stock Bonus And Restricted Stock Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockBonusAndRestrictedStockGrantsInPeriod
94112 shares
CY2012 lxrx Share Based Compensation Arrangement By Share Based Payment Award Stock Bonus And Restricted Stock Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockBonusAndRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue
1.70
CY2011 lxrx Share Based Compensation Arrangement By Share Based Payment Award Stock Bonus And Restricted Stock Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardStockBonusAndRestrictedStockGrantsInPeriodWeightedAverageGrantDateFairValue
1.81
CY2012Q4 lxrx Shares Issued Pursuant To Restricted Stock Awards Non Employee Directors Equity Incentive Plan
SharesIssuedPursuantToRestrictedStockAwardsNonEmployeeDirectorsEquityIncentivePlan
94112 shares
CY2012Q4 lxrx Shares Issued Pursuant To Restricted Stock Units Equity Incentive Plan
SharesIssuedPursuantToRestrictedStockUnitsEquityIncentivePlan
518250 shares
CY2012Q4 lxrx Shares Issued Pursuant To Stock Bonus Awards Equity Incentive Plan
SharesIssuedPursuantToStockBonusAwardsEquityIncentivePlan
740300 shares
CY2012 lxrx Shares Issued To Symphony Designees Value
SharesIssuedToSymphonyDesigneesValue
35000000 USD
CY2010 lxrx Shares Issued To Symphony Designees Value
SharesIssuedToSymphonyDesigneesValue
0 USD
CY2011 lxrx Shares Issued To Symphony Designees Value
SharesIssuedToSymphonyDesigneesValue
0 USD
CY2011 lxrx Stock Based Compensation Expense Associated With General And Administrative Expense
StockBasedCompensationExpenseAssociatedWithGeneralAndAdministrativeExpense
2458000 USD
CY2012 lxrx Stock Based Compensation Expense Associated With General And Administrative Expense
StockBasedCompensationExpenseAssociatedWithGeneralAndAdministrativeExpense
2822000 USD
CY2010 lxrx Stock Based Compensation Expense Associated With General And Administrative Expense
StockBasedCompensationExpenseAssociatedWithGeneralAndAdministrativeExpense
2308000 USD
CY2010 lxrx Stock Based Compensation Expense Associated With Research And Development Expense
StockBasedCompensationExpenseAssociatedWithResearchAndDevelopmentExpense
3170000 USD
CY2011 lxrx Stock Based Compensation Expense Associated With Research And Development Expense
StockBasedCompensationExpenseAssociatedWithResearchAndDevelopmentExpense
3249000 USD
CY2012 lxrx Stock Based Compensation Expense Associated With Research And Development Expense
StockBasedCompensationExpenseAssociatedWithResearchAndDevelopmentExpense
3673000 USD
CY2010Q1 lxrx Stock Issued During Period To Invus Shares
StockIssuedDuringPeriodToInvusShares
94270206 shares
CY2012Q4 lxrx Stock Issued During Period To Invus Shares
StockIssuedDuringPeriodToInvusShares
3000000 shares
CY2012 lxrx Stock Option Exercise Price As Percent Of Value Of Common Stock
StockOptionExercisePriceAsPercentOfValueOfCommonStock
1.00
CY2012Q4 lxrx Stock Options Exercised Equity Incentive Plan
StockOptionsExercisedEquityIncentivePlan
5087155 shares
CY2012Q4 lxrx Stock Options Exercised Non Employee Directors Equity Incentive Plan
StockOptionsExercisedNonEmployeeDirectorsEquityIncentivePlan
0 shares
CY2010 lxrx Structuring And Legal Fees Originally Allocated To Noncontrolling Interest
StructuringAndLegalFeesOriginallyAllocatedToNoncontrollingInterest
2300000 USD
CY2010Q3 lxrx Symphon Fair Value Of Base And Contingent Payments
SymphonFairValueOfBaseAndContingentPayments
45600000 USD
CY2010Q3 lxrx Symphony Base Payment Discount Rate
SymphonyBasePaymentDiscountRate
0.14
CY2012Q3 lxrx Symphony Base Payment In Shares
SymphonyBasePaymentInShares
13237519 shares
CY2012Q3 lxrx Symphony Base Payment Obligation
SymphonyBasePaymentObligation
35000000 USD
CY2010Q3 lxrx Symphony Contingent Payment Discount Rate
SymphonyContingentPaymentDiscountRate
0.18
CY2010Q3 lxrx Symphony Contingent Payment Maximum
SymphonyContingentPaymentMaximum
45000000 USD
CY2010Q3 lxrx Symphony Icon Goodwill
SymphonyIconGoodwill
18700000 USD
CY2010 lxrx Taconic Revenue
TaconicRevenue
1700000 USD
CY2011 lxrx Taconic Revenue
TaconicRevenue
800000 USD
CY2012 lxrx Taconic Revenue
TaconicRevenue
700000 USD
CY2012Q4 lxrx Taconic Total Cash Received
TaconicTotalCashReceived
6700000 USD
CY2012Q4 lxrx Tigm Per Job Payment Amount
TigmPerJobPaymentAmount
2415 USD
CY2012Q4 lxrx Total Shares That May Be Issued Equity Incentive Plan
TotalSharesThatMayBeIssuedEquityIncentivePlan
50000000 shares
CY2005Q3 lxrx Tx Enterprise Fund Award
TxEnterpriseFundAward
35000000 USD
CY2012Q4 lxrx Total Shares That May Be Issued Non Employee Directors Equity Incentive Plan
TotalSharesThatMayBeIssuedNonEmployeeDirectorsEquityIncentivePlan
1500000 shares
CY2005Q3 lxrx Tx Enterprise Fund Award To Texas Am University System
TxEnterpriseFundAwardToTexasAmUniversitySystem
15000000 USD
CY2009Q4 lxrx Unamortized Balance Of Purchase Option
UnamortizedBalanceOfPurchaseOption
3100000 USD
CY2004Q2 lxrx Woodlands Cash Paid
WoodlandsCashPaid
20800000 USD
CY2004Q2 lxrx Woodlands Mortgage
WoodlandsMortgage
34000000 USD
CY2012 dei Amendment Flag
AmendmentFlag
false
CY2012 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2012 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2012 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012 dei Document Period End Date
DocumentPeriodEndDate
2012-12-31
CY2012 dei Document Type
DocumentType
10-K
CY2012 dei Entity Central Index Key
EntityCentralIndexKey
0001062822
CY2013Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
513002541 shares
CY2012 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2012Q2 dei Entity Public Float
EntityPublicFloat
446300000 USD
CY2012 dei Entity Registrant Name
EntityRegistrantName
LEXICON PHARMACEUTICALS, INC./DE
CY2012 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No

Files In Submission

Name View Source Status
0001062822-13-000008-index-headers.html Edgar Link pending
0001062822-13-000008-index.html Edgar Link pending
0001062822-13-000008.txt Edgar Link pending
0001062822-13-000008-xbrl.zip Edgar Link pending
exh1015formofrestrictedsto.htm Edgar Link pending
exh231ernst_youngconsent10.htm Edgar Link pending
exh311certificationofprinc.htm Edgar Link pending
exh312certificationofprinc.htm Edgar Link pending
exh321certificationofprinc.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
form10k12312012.htm Edgar Link pending
form10k12312012_charta01.jpg Edgar Link pending
lxrx-20121231.xml Edgar Link completed
lxrx-20121231.xsd Edgar Link pending
lxrx-20121231_cal.xml Edgar Link unprocessable
lxrx-20121231_def.xml Edgar Link unprocessable
lxrx-20121231_lab.xml Edgar Link unprocessable
lxrx-20121231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending